Completed PHASE1 INTERVENTIONAL 16-arm NCT02185794

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection

Sponsor: Gilead Sciences

Conditions Hepatitis C Virus Infection

Interventions Placebo to match voxilaprevir SOF/VEL Voxilaprevir

Updated 9 times since 2017 Last updated: Aug 28, 2020 Started: Jun 13, 2014 Primary completion: Dec 22, 2014 Completion: Sep 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Hepatitis C Virus Infection and is currently completed. Gilead Sciences leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Oct 2020 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 4 earlier versions

Sep 2020 — Oct 2020 [monthly]

Completed PHASE1
Jun 2018 — Sep 2020 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gilead Sciences

Data source: Gilead Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Berlin, United States , Costa Mesa, United States , DeLand, United States , Kansas City, United States , Knoxville, United States , Marlton, United States , Orlando, United States , Philadelphia, United States , San Antonio, United States , San Juan, Puerto Rico and 1 more location